152 related articles for article (PubMed ID: 4924341)
1. Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
Knopp W
Neurology; 1970 Dec; 20(12):23-30. PubMed ID: 4924341
[No Abstract] [Full Text] [Related]
2. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
Muenter MD
Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
[No Abstract] [Full Text] [Related]
3. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
[No Abstract] [Full Text] [Related]
4. Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
Knopp W
Neurology; 1970 Dec; 20(12):Suppl:23-30. PubMed ID: 4921585
[No Abstract] [Full Text] [Related]
5. [Clinical study of L-dopa in Parkinson's disease].
Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
[No Abstract] [Full Text] [Related]
6. Permanent dementia in idiopathic Parkinsonism treated with levodopa.
Wolf SM; Davis RL
Arch Neurol; 1973 Oct; 29(4):276-8. PubMed ID: 4728189
[No Abstract] [Full Text] [Related]
7. Levodopa and amantadine in the treatment of Parkinsonism.
Critchley E
Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
[No Abstract] [Full Text] [Related]
8. The Eaton Collaborative Study of levodopa therapy in parkinsonism: a summary.
Keenan RE
Neurology; 1970 Dec; 20(12):46-59. PubMed ID: 5531294
[No Abstract] [Full Text] [Related]
9. [Psychiatric complications of L-Dopa treatment of parkinsonism].
Refsum H
Tidsskr Nor Laegeforen; 1973 Apr; 93(10):680-5. PubMed ID: 4755082
[No Abstract] [Full Text] [Related]
10. Start hesitation--a side effect of long-term levodopa therapy.
Ambani LM; Van Woert MH
N Engl J Med; 1973 May; 288(21):1113-5. PubMed ID: 4697941
[No Abstract] [Full Text] [Related]
11. Side effects from levodopa.
Ray I
Can Med Assoc J; 1972 Jul; 107(1):19. PubMed ID: 5042883
[No Abstract] [Full Text] [Related]
12. Levodopa in parkinson's disease--Australian collaborative trial.
Selby G
Med J Aust; 1973 Mar; 1(12):577-85. PubMed ID: 4700544
[No Abstract] [Full Text] [Related]
13. [Preliminary report on the action of cyclobenzaprine (MK-130) in Parkinson's disease].
Molina-Negro P; Illingworth RA
Union Med Can; 1973 Feb; 102(2):303-8. PubMed ID: 4709461
[No Abstract] [Full Text] [Related]
14. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa].
Megna GF; Puca FM; Leggiadro N; Micalizzi V; Pigneri MT
Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429
[No Abstract] [Full Text] [Related]
15. [Treatment of Parkinson's disease with L-dopa. 77 cases].
Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
[No Abstract] [Full Text] [Related]
16. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
Muenter MD; Dinapoli RP; Sharpless NS; Tyce GM
Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
[No Abstract] [Full Text] [Related]
17. [Levodopa and Parkinsonism. A double-blind study].
Pakkenberg H; Dupont E; Garde B; Hansen E; Melsen S; Vestberg F
Ugeskr Laeger; 1971 Nov; 133(46):2275-9. PubMed ID: 4944650
[No Abstract] [Full Text] [Related]
18. The comparative value of amantadine and levodopa.
Dallos V; Heathfield K; Stone P; Allen F
Postgrad Med J; 1972 Jun; 48(560):354-8. PubMed ID: 4558895
[TBL] [Abstract][Full Text] [Related]
19. [L-tryptophan therapy of DOPA psychoses].
Birkmayer W; Neumayer E
Nervenarzt; 1972 Feb; 43(2):76-8. PubMed ID: 4501978
[No Abstract] [Full Text] [Related]
20. Behavioral effects of l-dopa in man.
Goodwin FK
Semin Psychiatry; 1971 Nov; 3(4):477-92. PubMed ID: 5173049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
